Recent findings confirmed benefit from metastasis-directed therapy in oligometastatic hormone sensitive prostate cancer (omHSPC). However, current landscape of systemic treatment suggests that patients could benefit, at the same time, from early initiation of intensified hormonal treatments. In this commentary, we performed an overview about literature evidence aiming to overcome this issue and provide the maximum clinical benefit to the patients, taking advantage of modern imaging (e.g. PSMA PET/CT), ablative local treatment and newest systemic therapies.
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer / Francolini, Giulio; Di Cataldo, Vanessa; Detti, Beatrice; Simontacchi, Gabriele; Loi, Mauro; Valzano, Marianna; Desideri, Isacco; Meattini, Icro; Mangoni, Monica; Livi, Lorenzo. - In: CLINICAL & EXPERIMENTAL METASTASIS. - ISSN 0262-0898. - ELETTRONICO. - (2022), pp. 0-0. [10.1007/s10585-022-10187-2]
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer
Francolini, Giulio;Di Cataldo, Vanessa;Detti, Beatrice;Simontacchi, Gabriele;Loi, Mauro;Valzano, Marianna;Desideri, Isacco;Meattini, Icro;Mangoni, Monica;Livi, Lorenzo
2022
Abstract
Recent findings confirmed benefit from metastasis-directed therapy in oligometastatic hormone sensitive prostate cancer (omHSPC). However, current landscape of systemic treatment suggests that patients could benefit, at the same time, from early initiation of intensified hormonal treatments. In this commentary, we performed an overview about literature evidence aiming to overcome this issue and provide the maximum clinical benefit to the patients, taking advantage of modern imaging (e.g. PSMA PET/CT), ablative local treatment and newest systemic therapies.File | Dimensione | Formato | |
---|---|---|---|
2022_Francolini et al_Clin Exp Met.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
489.54 kB
Formato
Adobe PDF
|
489.54 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.